Literature DB >> 3567045

Ranitidine and cimetidine; drug interactions with single dose and steady-state nifedipine administration.

S R Smith, M J Kendall, J Lobo, A Beerahee, D B Jack, M R Wilkins.   

Abstract

The effect of ranitidine 300 mg once daily and cimetidine 800 mg once daily on the disposition of nifedipine was studied in two groups of 12 volunteers. Both investigations were placebo-controlled cross-over studies. The first group received ranitidine, cimetidine or placebo for 5 days with 20 mg nifedipine given on the 5th day. Each period was separated by 1 week. The second group received nifedipine 10 mg three times daily for 5 days together with the H2-receptor antagonist or placebo. Cimetidine produced a significant increase in the AUC of both single and steady state dosing of nifedipine. Peak nifedipine levels were significantly increased only in the chronic dose study compared to placebo. Ranitidine did not produce any significant changes in either study.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3567045      PMCID: PMC1386229          DOI: 10.1111/j.1365-2125.1987.tb03050.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  [Ranitidine-nifedipine interaction].

Authors:  W Kirch; H Hoensch; E E Ohnhaus; H D Janisch
Journal:  Dtsch Med Wochenschr       Date:  1984-08-03       Impact factor: 0.628

2.  Cimetidine--benzodiazepine interactions.

Authors:  R J Mangini
Journal:  Am J Hosp Pharm       Date:  1982-02

3.  Interaction of H2-receptor antagonists with drug-metabolizing enzymes.

Authors:  J A Bell; A J Gower; L E Martin; E N Mills; W P Smith
Journal:  Biochem Soc Trans       Date:  1981-02       Impact factor: 5.407

Review 4.  Drug interactions with cimetidine: an update.

Authors:  M C Gerber; G A Tejwani; N Gerber; J R Bianchine
Journal:  Pharmacol Ther       Date:  1985       Impact factor: 12.310

5.  Cytochrome P-450 and ethoxycoumarin-deethylation in rat gastric microsomes: induction by 3-methylcholanthrene and inhibition by cimetidine.

Authors:  P Borm; A Bast; A Frankhuijzen-Sierevogel; J Noordhoek
Journal:  Biochem Biophys Res Commun       Date:  1981-09-30       Impact factor: 3.575

6.  The effect of cimetidine on in vitro and in vivo microsomal drug metabolism in the rat.

Authors:  O Pelkonen; J Puurunen
Journal:  Biochem Pharmacol       Date:  1980-11-15       Impact factor: 5.858

7.  Determination of nifedipine in human plasma by capillary gas chromatography with nitrogen detection.

Authors:  M T Rosseel; M G Bogaert
Journal:  J Chromatogr       Date:  1983-11-25

8.  Effect of cimetidine on microsomal drug metabolism in man.

Authors:  J Puurunen; E Sotaniemi; O Pelkonen
Journal:  Eur J Clin Pharmacol       Date:  1980-08       Impact factor: 2.953

9.  [Effect of cimetidine and ranitidine on the pharmacokinetics and anti-hypertensive effect of nifedipine].

Authors:  W Kirch; H D Janisch; H Heidemann; K Rämsch; E E Ohnhaus
Journal:  Dtsch Med Wochenschr       Date:  1983-11-18       Impact factor: 0.628

10.  Cimetidine and ranitidine: comparison of effects on hepatic drug metabolism.

Authors:  D A Henry; I A Macdonald; G Kitchingman; G D Bell; M J Langman
Journal:  Br Med J       Date:  1980-09-20
View more
  18 in total

Review 1.  Clinical relevance of cimetidine drug interactions.

Authors:  A F Shinn
Journal:  Drug Saf       Date:  1992 Jul-Aug       Impact factor: 5.606

2.  Influence of the H2-receptor antagonists cimetidine and ranitidine on the pharmacokinetics of nimodipine in healthy volunteers.

Authors:  W Mück; W Wingender; M Seiberling; E Woelke; K D Rämsch; J Kuhlmann
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  Lack of effect of co-trimoxazole on the pharmacokinetics and pharmacodynamics of nifedipine.

Authors:  C Edwards; S Monkman; S Cholerton; M D Rawlins; J R Idle; R E Ferner
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335

Review 4.  Calcium antagonists in patients with heart failure. A review.

Authors:  H Reicher-Reiss; E Barasch
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

Review 5.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

Review 6.  Calcium channel antagonists: Part VI: Clinical pharmacokinetics of first and second-generation agents.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1989-08       Impact factor: 3.727

Review 7.  Clinical pharmacokinetics of calcium antagonists. An update.

Authors:  J G Kelly; K O'Malley
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

Review 8.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

9.  Effect of concomitant administration of cimetidine and ranitidine on the pharmacokinetics and electrocardiographic effects of terfenadine.

Authors:  P K Honig; D C Wortham; K Zamani; D P Conner; J C Mullin; L R Cantilena
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

10.  The pharmacokinetics and pharmacodynamics of nifedipine at steady state during concomitant administration of cimetidine or high dose ranitidine.

Authors:  A Khan; S J Langley; F G Mullins; J S Dixon; S Toon
Journal:  Br J Clin Pharmacol       Date:  1991-10       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.